0001181431-12-003824.txt : 20120125
0001181431-12-003824.hdr.sgml : 20120125
20120125160859
ACCESSION NUMBER: 0001181431-12-003824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120124
FILED AS OF DATE: 20120125
DATE AS OF CHANGE: 20120125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ehrlich Christopher B
CENTRAL INDEX KEY: 0001293973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51967
FILM NUMBER: 12544902
MAIL ADDRESS:
STREET 1: C/O INTERWEST PARTNERS
STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: (510) 215-3500
MAIL ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
rrd330175.xml
EHRLICH GRANT
X0304
4
2012-01-24
0
0001178711
Transcept Pharmaceuticals Inc
TSPT
0001293973
Ehrlich Christopher B
C/O TRANSCEPT PHARMACEUTICALS, INC.
1003 W. CUTTING BLVD, SUITE 110
POINT RICHMOND
CA
94804
1
0
1
0
Common Stock (right to buy)
8.18
2012-01-24
4
A
0
7000
0
A
2022-01-24
Common Stock
7000
7000
D
The option vests in twelve equal monthly installments beginning on February 24, 2012.
/s/ Marilyn Wortzman, by power of attorney
2012-01-25